The presentation will explore the pathophysiology and classification of myelodysplastic syndromes (MDS), with an emphasis on treatment strategies for different MDS subtypes. Current risk stratification tools and classification systems used to guide therapeutic decisions will be covered. Additionally, the presentation will review the efficacy of available treatments and the latest clinical trial data, focusing on emerging therapies to enhance evidence-based, patient-centered care in pharmacy practice. 

Microsoft Teams Meeting link to join the live session: Join the meeting now

Speaker: Kevin D. Ríos Martínez, PGY2 Oncology Pharmacy Resident – Aurora Health Care Metro, Inc  

Objectives: ​​ 

  • Recall the pathophysiology and classification of myelodysplastic syndromes (MDS), including subtype characteristics and their prognostic significance to guide prognosis and inform treatment decisions. 
  • Assess the efficacy and clinical application of treatment options for patients with lower- and higher-risk MDS based on current guidelines and individual patient factors. 
  • Evaluate recent clinical trial data and emerging therapeutic strategies in MDS to support evidence-based, patient-centered care. 
  • Formulate a medication plan for a patient with MDS based on disease risk classification, symptom burden, and patient-specific factors. 

Target Audience:​ Advocate Pharmacists, Physicians, Nurses, and other interested healthcare professionals

Disclosure:​ The planner(s) and speaker(s) have indicated that there are no relevant financial relationships with any ineligible companies to disclose. 

Session date: 
06/10/2025 - 2:00pm to 3:00pm CDT
Location: 
ASLMC Stiemke Auditorium and Virtual via Teams
United States
See map: Google Maps
Add to calendar: 
  • 1.00 AMA PRA Category 1 Credit™
    Aurora Health Care is accredited by the Wisconsin Medical Society to provide continuing medical education for physicians. Aurora Health Care designates this activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.
  • 1.00 Attendance
    Attendance Credit
    • 1.00 Approved AMA PRA Category 1 Credit™
  • 1.00 Continuing Nursing Education (CE)
    Aurora Health Care is an approved provider of continuing nursing education by the Wisconsin Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation. 1.00 contact hours have been awarded to this activity by the Wisconsin Nursing Association. To receive contact hours, participants must attend the entire activity.
  • 1.00 Continuing Pharmacy Education (CPE)
    Aurora Health Care Department of Pharmacy Services is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
Please login or register to take this course.